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Abstract
Introduction: The aim of this study was to determine the incidence of intra-abdominal hypertension (IAH) in
patients with two or more categorized risk factors (CRF) for IAH, and their morbidity and mortality during their
intensive care unit (ICU) stay.
Methods: Prospective cohort study carried out at a medical ICU. A total of 151 medical patients were enrolled
during a period of 3 months. After ICU whole staff training, we conducted daily screening of the four CRF for IAH
based on the World Society of Abdominal Compartment Syndrome (WSACS) guidelines (namely, diminished
abdominal wall compliance, increased intraluminal content, increased abdominal content, and capillary leak
syndrome or fluid resuscitation). In those patients with risk factors of at least two different categories (≥2 CRF),
intra-abdominal pressure (IAP) was measured every 8 h during ICU stay. Data included demographics, main
diagnosis on admission, severity scores, cumulative fluid balance, daily mean IAP, resolution of IAH, days of ICU and
hospital stay, and mortality.
Results: Eighty-seven patients (57.6%) had ≥2 CRF for IAH, 59 (67.8%) out of whom developed IAH. Patients with
≥2 CRF had a significantly higher mortality rate (41.4 vs. 14.3%, p < 0.001). Patients with IAH had higher body mass
index, severity scores, organ dysfunctions/failures, number of CRF for IAH, days of ICU/hospital stay and hospital
mortality rate (45.8 vs. 32.1%, p = 0.22). Non-resolution of IAH was associated with a higher mortality rate (64.7 vs.
35.3%, p = 0.001). None of the cohort patients developed abdominal compartment syndrome. The multivariate
analysis showed that IAH development (odds ratio (OR) 4.09; 95% confidence interval (CI) 0.83-20.12) was a non-
independent risk factor for mortality, and its non-resolution (OR 13.15; 95% CI 22.13-81.92) was an independent risk
factor for mortality.
Conclusions: Critically ill medical patients admitted to ICU with ≥2 CRF have high morbidity, mortality rate, and
incidence of IAH, so IAP should be measured and monitored as recommended by the WSACS. Our study
highlights the importance of implementing screening and assessment protocols for an early diagnosis of IAH.
Introduction
Intra-abdominal hypertension (IAH) is associated with
adverse outcomes in critically ill patients [1,2]. Elevated
intra-abdominal pressure (IAP) above physiologic limits
has deleterious effects on end-organ function due to
pathophysiologic changes such as a drop in cardiac
output, diminished chest wall compliance, decreased
renal and visceral blood flow, and increased intracranial
pressure [3-11].
IAH has traditionally been associated with patients
undergoing abdominal surgery and trauma patients who
require aggressive volume resuscitation [12-16]. Several
studies have demonstrated that IAH is also frequently
present in critically ill nonsurgical patients, and is now
considered to be associated with the general process of
inflammation and resuscitation [17-22]. However,
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mortality rates in medical patients from data of pub-
lished clinical trials is difficult, mainly due to three rea-
sons: firstly, the absence of uniform definitions before
consensus guidelines, which allow us to reproduce and
interpret the results; secondly, the different methods
used for IAP measurement; and lastly, the fact that most
clinical studies have been performed on mixed popula-
tions (both medical and surgical).
The World Society of Abdominal Compartment Syn-
drome (WSACS) has published a consensus statement
including definitions and recommendations for the screen-
ing and management of IAH and abdominal compartment
syndrome (ACS) [23,24]. Following this consensus, the
aim of this study was to determine the incidence of IAH
in exclusively critically ill medical patients with high risk
of IAH development, and their morbidity and mortality
during their intensive care unit (ICU) stay.
Materials and methods
This study was conducted in a university hospital medi-
cal ICU in accordance with a protocol that was
approved by the local ethics committee. The study ful-
filled the requirements of the Declaration of Helsinki,
and included an informed consent from the patients on
admission (or their family if necessary) to participate
and publish the results.
All medical patients admitted to the ICU during a
three-month period and expected to stay > 24 h were
prospectively enrolled, provided they needed a bladder
catheter. Exclusion criteria were ICU stay < 24 h, age <
18 years, pregnancy, contraindication for intravesical
pressure measurement (pelvic fracture, hematuria, or
neurogenic bladder), and bladder surgery. WSACS con-
sensus for assessment of IAH was implemented as a
new protocol [23,24].
Data collection
Demographic data
Age, gender, body mass index (BMI) expressed as kg/m
2
[25], main diagnosis on admission, cumulative fluid bal-
ance, length of ICU and hospital stay, and hospital mor-
tality were considered in collecting the patients’ data.
Patients were followed until death or hospital discharge,
whatever came first.
Organ dysfunction
On admission, APACHE II (Acute Physiology and
Chronic Health Evaluation) and SOFA (Sequential
Organ Failure Assessment) scores were recorded using
the worst values of the day [26,27]. Organ dysfunction/
failure was evaluated using the SOFA score (dysfunction
=s u b s c o r e≤2, failure = subscore ≥3). The SOFA maxi-
mum score was based on the worst value of each organ
system during the ICU stay.
Risk factors for IAH
All patients were prospectively screened for risk factors
(RF) of IAH on admission and daily during their ICU
stay until death or discharge, based on four categories
from the WSACS algorithm (Table 1). Those patients
who presented any RF of at least two different categories
(≥2 categorized risk factors (CRF)), at any time on
admission or during the ICU stay, were considered to
have a high risk of developing IAH, and IAP was moni-
tored (starting the day they were found to have ≥2
CRF). Those patients with < 2 CRF on admission and
daily during the ICU stay were considered to have a low
risk of developing IAH according to WSACS recom-
mendations and their IAP measurement was not
recorded. For the main analysis, we calculated the num-
ber of RF as categories (one minimum, four maximum)
on admission (first 24 h) and during the ICU stay (mean
RF categories present per day).
IAP measurement
IAP was measured intravesically using a closed-system
Foley bladder catheter according to the modified Kron
technique [28,29] with an instillation volume of 25 ml
of saline. Abdominal perfusion pressure (APP) was cal-
culated as mean arterial pressure minus IAP [30,31].
Measurements of IAP and APP were recorded every 8 h
in patients with ≥2 CRF until resolution of IAH (in case
it developed), death, or discharge from the ICU. IAH
was defined as a repeated (at least three consecutive
values separated by 8 h) elevation of IAPmin (the lowest
value of each of the three IAP measures) ≥12 mmHg
[23]. For the main analysis, IAPmean and APPmean (mean
of the three daily values) were calculated per day.
IAH characteristics
We recorded the day of onset, days of sustained IAH,
surgical abdominal decompression, and resolution. Reso-
lution of IAH was defined as a sustained IAPmin <1 2
mmHg in all measurements recorded every 8 h for a
minimum of 48 h; and non-resolution was defined as a
sustained IAPmin ≥ 12 mmHg in all measurements until
death or discharge from the ICU. IAH was classified
according to the time of onset (on admission or during
ICU stay) and the development of symptoms (acute,
over a period of hours; subacute, over a period of days;
or chronic, over a period of months/years). We also
recorded the grade of maximal IAP reached during the
ICU stay (I, 12-15; II, 16-20; III, 21-25; IV, ≥25 mmHg)
[23].
Statistical analysis
Univariate analysis
Continuous non-normally distributed variables were
expressed as the median and interquartile range and
compared using the nonparametric Mann-Whitney test.
Continuous normally distributed variables were
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using the student’s t test. Categorical variables were
expressed as numbers and percentages and compared
using the chi-square test or Fisher exact test. All p
values were two-tailed, and p <. 0 5w a sc o n s i d e r e da s
statistically significant.
Multivariate analysis
The prognostic relevance of two different parameters
was analyzed: variables associated with development of
IAH and the prognostic value of IAH and its non-reso-
lution. Backward multiple logistic models were used,
including all the variables yielding p <. 2b yu n i v a r i a t e
analysis and those considered clinically relevant. Possible
interactions were tested. The results were summarized
as odds ratios their respective 95% confidence intervals.
The area under the receiver operating characteristic
(ROC) curve was used to assess discrimination; an area
under the ROC curve of 1.0 denotes perfect discrimina-
tion, whereas a value close to 0.50 indicates no apparent
accuracy. The Hosmer-Lemeshow goodness-of-fit test
was used to evaluate agreement between the observed
and expected results across all the probability strata of
the outcome of interest (calibration); p > .05 indicates a
good fit for the model. Kaplan-Meier curves for survival
at 28-day hospital stay were constructed for subgroups
with IAH.
Results
Criteria for IAP monitoring and incidence of IAH (Figures 1
and 2)
During the study period, 204 patients were admitted.
Fifty-three were excluded: 5 refused to participate, 22
had ICU stay < 24 hours, 12 had contraindications for
intravesical pressure measurement or bladder surgery,
11 did not require urinary catheterization, 2 were < 18
years and 1 was pregnant. We finally enrolled 151
medical patients, and the entire protocol was com-
pleted in all of them. Main diagnosis on admission was
Table 1 Categorized risk factors for intra-abdominal hypertension
Diminished abdominal wall compliance
￿ Mechanical ventilation
￿ Abdominal surgery with primary fascial or tight closure
￿ Major trauma
￿ Major burns
￿ Prone positioning
￿ Head of bed > 30 degrees
￿ Body mass index ≥ 30 kg/m
2 or morbid obesity
Increased intra-luminal contents
￿ Gastroparesis (gastric dilation or gastric residual > 500 mL).
￿ Ileus, paralytic or mechanical (abdominal distention or absence of bowel sounds)
￿ Colonic pseudo-obstruction
Increased abdominal contents
￿ Hemoperitoneum or pneumoperitoneum
￿ Ascites secondary to liver dysfunction
￿ Ascites secondary to liver dysfunction
￿ Other intra-abdominal injuries (peritonitis, abscess)
Capillary leak syndrome or fluid resuscitation
￿ Acidosis (arterial pH < 7.2)
￿ Hypotension (systolic blood pressure < 90 mmHg or mean arterial pressure < 70 mmHg or a systolic blood pressure decrease > 40 mmHg or
> 2 standard deviation below normal for age in the absence of other causes of hypotension)
￿ Hypothermia (core temperature < 33°C).
￿ Multiple transfusions (> 10 units of blood)
￿ Coagulopathy (platelets < 55,000/mm
3 or prothrombin time < 15 s or partial thromboplastin time > 2 times normal or international
standardized ratio > 1.5)
￿ Massive fluid resuscitation (> 5 L of colloid or crystalloid)
￿ Acute pancreatitis
￿ Oliguria (urine output < 500 mL).
￿ Sepsis (American-European Consensus Conference definitions)
￿ Major trauma
￿ Major burns
￿ Damage control laparotomy
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Page 3 of 13cardiopulmonary disease (Table 2). Sixty-four patients
presented < 2 CRF (42.4%) on admission and during all
the ICU stay, and IAP was not measured; the remain-
ing 87 (57.6%) patients presented ≥2 CRF (high risk
group) for IAH (88.5% on admission and 11.5% during
ICU stay), and IAP was monitored following the study
protocol. In the high risk group, 59 of the 87 patients
developed IAH (67.8%): 35 on admission (59.3%) and
24 during the ICU stay (40.7%). Overall 67.8% of the
high risk group subjects developed IAH, 40.2% on
admission, and another 27.6% during the ICU stay.
Figure 2 shows the differences in the evolution of the
number of CRF during the ICU stay across different
subgroups of patients. Comparisons between survivors
and non-survivors in the study cohort and high risk
group are shown in Tables 3 and 4. There were no sta-
tistical differences in IAP levels between survivors and
non-survivors (11.8 vs. 12.0 mmHg, p =0 . 7 8 ) .
General characteristics for the comparison between high
risk and low risk groups (Table 5)
We compared patients with ≥2 CRF (n = 87) with those
with < 2 CRF for IAH (n = 64). Severity of illness, ICU
and hospital length of stay, and mortality rate (41.4 vs.
14.3%, p < 0.001) were significantly higher in the high
risk group.
General characteristics for the comparison between IAH
and non-IAH groups (Tables 6 and 7)
We compared patients who developed IAH with ≥2 CRF
(n = 59) with those who did not despite having ≥2C R F
(n = 28). Mortality rate was higher in patients with IAH,
although this did not reach statistical (45.8 vs. 32.1%,
p < 0.22) significance. Patients with IAH were older, had
a higher BMI, higher severity scores and proportion of
organ failure, and had a longer ICU and hospital stay.
Increased abdominal content (39 vs. 10.7%, p=0.007)
204 patients  
admitted to ICU  
n = 151 
included 
87 (57.6%) 
≥ 2 CFR for IAH 
(high-risk group) 
64 (42.4%) 
< 2 CFR for IAH 
59 (67.8%) 
IAH 
53 excluded 
28 (32.2%)  
No IAH 
35 on admission 
(59.3% of IAH  
and 40.2% of high-risk) 
24 during ICU stay 
(40.7% of IAH  
and 27.6% of high-risk) 
14 (40%) resolution 
21 (60%) non-resolution 
11 (45.8%) resolution 
13 (54.2%) non-resolution 
Figure 1 Algorithm and general results of the study cohort. IAH, intra-abdominal hypertension; ICU, intensive care unit; CRF, categorized risk
factors.
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also significantly higher.
General characteristics of patients with IAH (Table 8,
Figure 3)
Non-survivors had significantly higher severity scores,
number of organ failures, and CRF for IAH, both on
admission and during the ICU stay. The more com-
monly found subtypes of IAH were subacute (51
patients, 86.4%) and grade II (34 patients, 57.6%). IAH
was resolved in a high proportion of patients (42.4%)
and none presented ACS or required surgical abdominal
decompression. Patients in whom IAH was not resolved
(57.6%) had a significantly higher mortality rate than
patients whose condition was resolved (64.7 vs. 35.2%, p
= 0.001). Kaplan-Meier survival analysis for patients
with IAH on admission or during the ICU stay depend-
ing on resolution is shown in Figure 3.
Multivariate analysis: predictive and prognostic models
(Tables 9, 10 and 11)
Predictive model for IAH development in the high risk
group (87 patients with ≥2 CRF)
SOFA on admission, obesity, and number of CRF during
ICU stay (odds ratio (OR), 2.31; 95% confidence interval
(CI), 1.09 - 4.88) were independent predictors of IAH
development.
Predictive model of mortality in the high risk group (87
patients with ≥2 CRF)
IAH development was a non-independent predictor of
mortality (OR, 4.09; 95% CI, 0.83 - 20.12).
Predictive model of mortality in the IAH group (59 patients)
Non-resolution of IAH (OR, 13.15; 95% CI, 22.13 -
81.92), number of CRF during ICU stay (OR, 9.94; 95%
CI, 1.59-62.00), and age ≥65 years were independent
predictors of mortality. Even though the ROC curve
showed good discrimination, the Hosmer-Lemeshow
test indicated inadequate calibration across all the prob-
ability strata for mortality in the model.
A 
 
p < .01 each day 
 
B 
 
p > .05 each day 
 
C 
 
p > .05 each day 
Figure 2 Differences in the evolution of the number of
categorized risk factors during the ICU stay. Differences in the
evolution of the number of categorized risk factors during the ICU
stay across survivors and non-survivors in the study cohort (A),
patients with and without IAH (B), and patients with IAH on
admission or during the ICU stay (C). ICU, intensive care unit; IAH,
intra-abdominal hypertension.
Table 2 Main diagnosis of the study cohort on admission
Study cohort (n = 151)
Cardiopulmonary diagnosis 67 (44.4)
Acute/chronic liver failure 7 (4.6)
Acute pancreatitis 5 (3.3)
Gastrointestinal disease 8 (5.3)
Other intra-abdominal processes 4 (2.6)
Acute renal failure 13 (8.6)
Cardiac arrest 5 (3.3)
Neurologic disease 30 (19.9)
Other 12 (8)
Values are n (percent).
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Page 5 of 13Table 3 Categorized risk factors between survivors and non-survivors in the study cohort
Survivors (n = 109) Non-survivors (n = 42) p value
Number of categorized risk factors
On admission 1.5 ± 0.9 2.4 ± 1.1 < .001
During ICU stay 1.6 ± 1 2.8 ± 1.1 < .001
Risk factors during ICU stay
(n, percent)
Diminished abdominal wall compliance 75 (68.8) 39 (92.8) = .002
Increased intraluminal contents 20 (18.3) 24 (57.1) < .001
Increased abdominal contents 10 (9.2) 16 (38.1) < .001
Capillary leak syndrome/fluid resuscitation 61 (55.9) 36 (85.7) = .001
ICU, intensive care unit. Data are presented as mean ± standard deviation, unless otherwise indicated.
Table 4 Categorized risk factors between survivors and non-survivors in the high risk group
Survivors (n = 51) Non-survivors (n = 36) p value
Number of categorized risk factors
On admission 2.2 ± 0.8 2.7 ± 0.9 < .001
During ICU stay 2.6 ± 0.7 3.1 ± 0.8 < .001
Risk factors during ICU stay (n, percent)
Diminished abdominal wall compliance 48 (94.1) 35 (97.2) < .001
Increased intraluminal contents 20 (39.2) 24 (67.6) < .001
Increased abdominal contents 10 (19.6) 16 (44.4) < .001
Capillary leak syndrome/fluid resuscitation 45 (88.2) 34 (94.4) < .001
Categorized risk factors between survivors and non-survivors in the high risk group (87 patients with ≥2 categorized risk factors). ICU, intensive care unit. Data
are presented as mean ± standard deviation, unless otherwise indicated.
Table 5 General characteristics of the study cohort, and comparisons between patients
Study cohort ≥2 categorized risk factors <2 categorized risk factors p value
Patients (n, percent) 151 (100) 87 (57.6) 64 (42.4) -
Age (years) 56.7 ± 17.5 55.8 ± 17.2 58 ± 17.9 NS
Male gender (n, percent) 106 (70.2) 66 (75.9) 40 (62.5) NS
Body mass index (kilograms per square meter) 25.9 ± 5.3 26.3 ± 5.6 25.3 ± 4.9 NS
Acute Physiology and Chronic Health Evaluation score, points 20.1 ± 8.4 22.8 ± 7.9 16.5 ± 7.8 < .001
Sequential Organ Failure Assessment score on day 1, points 6.4 ± 3.9 7.9 ± 3.9 4.4 ± 2.7 < .001
Number of organ failures on day 1, points 3 ± 1.3 3.2 ± 1.3 2.2 ± 1.1 < .001
Sequential Organ Failure Assessment score maximum, points 8.1 ± 5.2 10.5 ± 5.1 4.8 ± 3.1 < .001
Number of organ failures maximum, points 3 ± 1.5 3.8 ± 1.5 2.3 ± 1.1 < .001
Positive cumulative fluid balance during ICU stay 59 (39.1) 34 (39) 25 (39) NS
ICU stay (days)
a 5 (3-12) 9 (4-25) 3 (2-4) < .001
Hospital stay (days)
a 16 (9-37) 24 (4-55) 13 (8-21) = .001
Hospital mortality (n, percent) 42 (27.8) 36 (41.4) 6 (14.3) < .001
Number of categorized risk factors
On admission 1.7 ± 1.0 2.4 ± 0.9 0.8 ± 0.4 < .001
During ICU stay 2.0 ± 1.1 2.8 ± 0.8 0.8 ± 0.3 < .001
Risk factors during ICU stay
b (n, percent)
Diminished abdominal wall compliance 114 (75.5) 83 (95.4) 31 (48.4) < .001
Mechanical ventilation 104 (68.9) 77 (88.5) 27 (42.2) < .001
Head of bed > 30° 135 (89.4) 83 (95.4) 52 (81.3) = .005
Body mass index ≥30 kg/m
2 36 (23.8) 26 (29.9) 10 (15.6) = .04
Increased intraluminal contents 44 (29.1) 44 (50.6) 0 (0) < .001
Gastroparesis 37 (24.5) 37 (42.5) 0 (0) < .001
Ileus 21 (13.9) 21 (24.1) 0 (0) < .001
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Increased abdominal contents 26 (17.2) 26 (29.9) 0 (0) < .001
Ascites/liver dysfunction 14 (9.3) 14 (16.1) 0 (0) = .001
Ascites of other causes 4 (2.6) 4 (4.6) 0 (0) NS
Capillary leak syndrome/fluid resuscitation 97 (64.2) 79 (90.8) 18 (28.1) < .001
Acidosis 32 (21.2) 28 (32.2) 4 (6.3) < .001
Hypotension 68 (45) 61 (70.1) 7 (10.9) < .001
Hypothermia 7 (4.6) 7 (8) 0 (0) = .01
Multiple transfusions 3 (2) 3 (3.4) 0 (0) NS
Coagulopathy 48 (31.8) 40 (46) 8 (12.5) < .001
Massive fluid resuscitation 49 (32.5) 40 (46) 9 (14.1) < .001
Acute pancreatitis 5 (3.3) 5 (5.7) 0 (0) NS
Oliguria 43 (28.5) 35 (40.2) 8 (12.5) < .001
Sepsis 68 (45) 56 (64.4) 12 (18.8) < .001
General characteristics of the study cohort, and comparisons between patients with ≥2 vs. <2 categorized risk factors for intra-abdominal hypertension.
aData are
presented as median and interquartile range.
bAbdominal surgery with primary fascial or tight closure, major trauma, major burns, prone positioning, colonic
pseudo-obstruction, hemoperitoneum or pneumoperitoneum; other intra-abdominal injuries and damage control laparotomy are not included due to the very
low number of patients with these risk factors. APACHE II, Acute Physiology and Chronic Health Evaluation; CRF, categorized risk factors; IAH, intra-abdominal
hypertension; ICU, intensive care unit; NS, not significant; SOFA, Sequential Organ Failure Assessment. Data are presented as mean ± standard deviation, unless
otherwise indicated.
Table 6 General characteristics of the patients with ≥2 categorized risk factors and comparisons between patients
≥2 Categorized risk
factors
Intra-abdominal
hypertension
No intra-abdominal
hypertension
p
value
Patients (n, percent) 87 (100) 59 (67.8) 28 (32.2)
Age (years) 55.8 ± 17.2 59.3 ± 16.4 48.5 ± 16.6 .006
Male gender (n, percent) 66 (75.9) 44 (74.6) 22 (78.6) NS
Body mass index (kilograms per square
meter)
26.3 ± 5.6 27.7 ± 5.6 23.4 ± 4.2 < .001
APACHE II score, points 22.8 ± 7.9 24.4 ± 7.8 19.5 ± 7.2 .007
SOFA score on day 1, points 7.9 ± 3.9 8.8 ± 4.0 6.2 ± 3.3 .004
Number of organ failures on day 1, points 3.2 ± 1.3 3.5 ± 1.3 2.5 ± 1.2 .002
SOFA score maximum, points 10.5 ± 5.1 11.7 ± 4.7 7.9 ± 4.9 .001
Number of organ failures maximum, points 3.8 ± 1.5 4.2 ± 1.4 3.0 ± 1.4 < .001
Positive cumulative fluid balance during ICU
stay
34 (39) 25 (42.4) 9 (32.1) NS
ICU stay (days)
a 9 (4-25) 11 (7-29) 4 (3-9) < .001
Hospital stay (days)
a 24 (4-55) 29 (13-61) 15 (6-34) .005
Hospital mortality (n, percent) 36 (41.4) 27 (45.8) 9 (32.1) NS
Number of categorized risk factors
On admission 2.4 ± 0.9 2.5 ± 0.9 2.1 ± 0.8 .05
During ICU stay 2.8 ± 0.8 2.9 ± 0.8 2.4 ± 0.6 .006
Risk factors during ICU stay
b (n, percent)
Diminished abdominal wall compliance 83 (95.4) 57 (96.6) 26 (92.9) NS
Mechanical ventilation 77 (88.5) 51 (86.4) 26 (92.9) NS
Head of bed > 30° 83 (95.4) 57 (96.6) 26 (92.9) NS
Body mass index ≥30 kg/m
2 26 (29.9) 24 (40.7) 2 (7.1) .001
Increased intraluminal contents 44 (50.6) 33 (55.9) 11 (39.3) NS
Gastroparesis 37 (42.5) 28 (47.5) 9 (32.1) NS
Ileus 21 (24.1) 16 (27.1) 5 (17.9) NS
Increased abdominal contents 26 (29.9) 23 (39) 3 (10.7) .007
Ascites/liver dysfunction 14 (16.1) 12 (20.3) 2 (7.1) NS
Ascites of other causes 4 (4.6) 4 (6.8) 0 (0) NS
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(Continued)
Capillary leak syndrome/fluid
resuscitation
79 (90.8) 55 (93.2) 24 (85.7) NS
Acidosis 28 (32.2) 22 (37.3) 6 (21.4) NS
Hypotension 61 (70.1) 46 (78) 15 (53.6) .02
Hypothermia 7 (8) 5 (8.5) 2 (7.1) NS
Multiple transfusions 3 (3.4) 2 (3.4) 1 (3.6) NS
Coagulopathy 40 (45.9) 30 (50.8) 10 (35.7) NS
Massive fluid resuscitation 40 (46) 30 (50.8) 10 (35.7) NS
Acute pancreatitis 5 (5.7) 5 (8.5) 0 (0) .005
Oliguria 35 (40.2) 27 (45.8) 8 (28.6) NS
Sepsis 56 (64.4) 40 (67.8) 16 (57.1) NS
IAP during ICU stay 12 ± 3 13 ± 1 8 ± 1 < .001
APP mean during ICU stay 74 ± 13 73 ± 12 74 ± 15 NS
General characteristics of the patients with ≥2 categorized risk factors, and comparisons between patients with and without intra-abdominal hypertension.
aData
are presented as median and interquartile range.
bAbdominal surgery with primary fascial or tight closure, major trauma, major burns, prone positioning, colonic
pseudo-obstruction, hemoperitoneum or pneumoperitoneum; other intra-abdominal injuries and damage control laparotomy are not included due to the very
low number of patients with these risk factors. APACHE II, APP, abdominal perfusion pressure; Acute Physiology and Chronic Health Evaluation; CRF, categorized
risk factors; IAH, intra-abdominal hypertension; IAP, intra-abdominal pressure (mmHg); ICU, intensive care unit; NS, not significant; SOFA, Sequential Organ Failure
Assessment. Data are presented as mean ± standard deviation, unless otherwise indicated.
Table 7 Comparison of organ failure according to SOFA score between IAH and non-IAH patients
Intra-abdominal hypertension(n = 59) No intra-abdominal hypertension (n = 28) p value
Organ failures on day 1
Respiratory 56 (94.9) 27 (96.5) NS
Circulatory 43 (72.8) 11 (39.2) < .003
Renal 32 (54.2) 4 (14.6) < .001
Hepatic 21 (35.6) 6 (21.4) NS
Neurological 28 (47.5) 16 (67.1) NS
Coagulation 28 (47.5) 7 (25) = .04
Organ failures during ICU stay
Respiratory 58 (98.4) 26 (92.8%) NS
Circulatory 47 (79.7) 16 (57.1%) = .02
Renal 38 (64.4) 6 (21.5%) < .001
Hepatic 32 (54.3) 8 (28.5%) = .02
Neurologic 37 (62.7) 18 (6.3%) NS
Coagulation 37 (62.7) 11 (3.3%) = .04
Comparison of organ failure according to SOFA score (Sequential Organ Failure Assessment Score) between IAH and non-IAH patients on admission and during
the entire ICU stay. IAH, intra-abdominal hypertension; ICU, intensive care unit; NS, not significant. Values are n (percent).
Table 8 Characteristics of patients with intra-abdominal hypertension and comparisons between survivors and non-
survivors
Intra-abdominal hypertension Survivors Non-survivors p value
Patients (n, percent) 59 (100) 32 (54.2) 27 (45.8) -
Age (years) 59.3 ± 16.4 55.7 ± 16.6 63.5 ± 15.5 NS
Male gender (n, percent) 44 (74.6) 23 (71.8%) 21 (77.8) NS
Body mass index (kilogram per square meter) 27.7 ± 5.6 27.8 ± 6.8 27.6 ± 3.9 NS
APACHE II score, points 24.4 ± 7.8 22.5 ± 8.8 26.6 ± 5.7 .03
SOFA score on day 1, points 8.8 ± 4 7.5 ± 3.7 10.2 ± 3.9 .009
Number of organ failures on day 1, points 1.7 ± 1.1 1.3 ± 1 2.2 ± 0.9 < .001
SOFA score maximum, points 11.7 ± 4.7 10.2 ± 4.2 13.5 ± 4.8 .006
Number of organ failures maximum 2.6 ± 1.3 2.3 ± 1.2 3.1 ± 1.3 .02
Number of categorized risk factors 2.5 ± 0.9 2.3 ± 0.8 2.8 ± 0.9 03
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This is a prospective epidemiologic study performed in a
population of exclusive critically ill medical patients fol-
lowing the WSACS guidelines for the assessment of IAH
(screening, IAP measurement, definitions, and classifica-
tion recommendations). Other published studies had been
performed in mixed populations (medical and surgical),
before the WSACS consensus statement, based on differ-
ent definitions of IAH or limited by incomplete assess-
ment in terms of screening or classification of the IAH
[17-21].
Our study revealed several interesting findings. Firstly,
there was a large number of patients with high risk (≥2
CRF) for IAH development, and the incidence of IAH in
this group was high; in addition, the mortality in this sub-
group was significantly higher as compared with the low
risk subgroup. Secondly, there was an association of IAH
with illness severity and the number/type of RF reported
in the literature. Thirdly, IAH was a predictor of mortality
in association with other clinical factors. And finally, non-
resolution of IAH was an independent predictive factor of
mortality. Our results support the importance of imple-
menting screening and assessment protocols, according to
WSACS recommendation, in order to identify a subgroup
of high risk patients with high mortality and high inci-
dence of IAH whom should be monitored for IAP.
Screening, risk factors and incidence of IAH
A large number of patients presented ≥2C R Ff o rI A H
development, and the incidence of IAH in this group
was high (67.8%) on admission or during the ICU stay.
In addition, several high risk patients without IAH
might have shown underestimated IAP levels because of
the different factors usually present in the critically ill
population, such as sedation or gastric/colonic decom-
pression. A high incidence of IAH had also been
reported in the literature [17-21]; however, when trying
to combine our results with previously described find-
ings, three main methodology issues should be
accounted for: a) incidence is recorded on admission or
during the first week; b) most reports refer to mixed
populations (both medical and surgical); c) definitions of
IAH differed across the studies (incidence rates can vary
depending on the threshold IAP level used as a diagnos-
tic criterion). Unlike previous studies, our study analyzes
the incidence of IAH in a high risk population on
Table 8 Characteristics of patients with intra-abdominal hypertension and comparisons between survivors and non-
survivors (Continued)
At admission 2.9 ± 0.8 2.7 ± 0.8 3.3 ± 0.7 .003
During ICU stay 5 (8.5) 3 (9.4) 2 (7.4) -
Classification of IAH according to
Presentation or development of symptoms (n, percent)
Acute 51 (86.4) 26 (81.2) 25 (92.6) -
Subacute 3 (5.1) 3 (9.4) 0 (0) NS
Chronic 6 (10.2) 3 (9.4) 3 (11.1) NS
Grade of IAP reached during ICU
stay (n, percent)
I (12-15 mmHg) 34 (57.6) 19 (59.4) 15 (55.5) NS
II (16-20 mmHg) 14 (23.7) 8 (25) 6 (22.2) NS
III (21-25 mmHg) 5 (8.5) 2 (6.2) 3 (11.1) NS
IV (> 25 mmHg) 13 ± 1 14 ± 2 13 ± 1 NS
IAP mean during ICU stay 73 ± 12 74 ± 12 71 ± 12 .001
APP mean during ICU stay 35 (59.3) 21 (65.6) 14 (51.8) NS
Time of IAH development (n, percent)
On admission 24 (40.7) 11 (34.4) 13 (48.1) NS
During ICU stay 1 (1-3) 1 (1-3) 1 (1-4) NS
Day of IAH development during ICU stay
a 8 (4-16) 7 (4-16) 9 (6-16) NS
Days with maintained IAH during ICU stay
a 34 (57.6) 12 (37.5) 22 (81.5)
Non-resolved IAH (n, percent)
Positive cumulative fluid balance at IAH diagnosis 49 (83) 27 (84.4) 22 (81.5)
Positive cumulative fluid balance during ICU stay 25 (42.4) 10 (31.2) 15 (55.5)
ICU stay (days)
a 1 (7-29) 12 (7-26) 12 (6-33)
Hospital stay after ICU (days)
a 29 (13-61) 34 (23-58) 16 (8-65)
aData are presented as median and interquartile range. APACHE II, Acute Physiology and Chronic Health Evaluation; APP, abdominal perfusion pressure; IAH,
intra-abdominal hypertension; IAP, intra-abdominal pressure (mmHg); ICU, intensive care unit; NS, not significant; SOFA, Sequential Organ Failure Assessment.
Data are presented as mean ± standard deviation, unless specified.
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Page 9 of 13admission and throughout the entire ICU stay, following
WSACS consensus guidelines, and exclusively in criti-
cally ill medical patients. Reintam et al. [17] and Vidal
et al. [18] have also used WSACS definitions for IAH,
and they report incidence rates of 37% in a mixed
population, and 43% in the medical subgroup of a
mixed population, respectively.
Numerous conditions predispose to IAH development,
and our results are consistent with those from other stu-
dies [20,21]. In the high risk group, we found an
Figure 3 Kaplan-Meier cumulative survival curve for different subgroups of patients with IAH. Kaplan-Meier cumulative survival curve for
different subgroups of patients with IAH: IAH on admission or during the ICU stay depending on resolution or non-resolution of IAH. IAH, intra-
abdominal hypertension; ICU, intensive care unit.
Table 9 Logistic regression model for predictors of development of IAH in the high risk group
Coefficients Odds ratio 95% confidence interval p value
Age ≥65 years 0.780 2.18 0.66-7.15 .19
Body mass index ≥30, kg/m
2 2.312 10.09 1.97-51.58 .005
SOFA score at admission 0.153 1.16 1.00-1.35 .04
Number of categorized risk factors for IAH during ICU stay 0.840 2.31 1.09-4.88 .02
Constant -3.408
Predictors of development of IAH in the group with ≥2 categorized risk factors for IAH (87 patients). CI, confidence interval; SOFA, Sequential Organ Failure
Assessment; IAH, intra-abdominal hypertension; ICU, intensive care unit. Area under receiver operating characteristic curve = 0.80; Hosmer-Lemeshow goodness-
of-fit (x
2 = 4.22; p = 0.835).
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Page 10 of 13association between IAH and the CRF proposed by the
WSACS, specially the increased abdominal content.
O b e s i t ya n dt h en u m b e ro fC R Ff o rI A Hd u r i n gI C U
stay were independent predictors of IAH development.
Data on fluid balance were only qualitative (positive or
negative), and the association between IAH and massive
fluid loading in the presence of sepsis and/or capillary
leak described in the literature could not be studied.
Severity scores and organ failure in patients with IAH
Increases in IAP have deleterious effects on end-organ sys-
tem function by compromising perfusion, thus leading to
multiorganic dysfunction (MOD) and poor outcome. In
our population, IAH was significantly associated with
higher severity of illness scores and incidence of organ fail-
ure. In addition, the study design allowed us to compare
organ impairment during ICU stay between patients with
and without IAH (Table 5). Previous studies analyzed
organ impairment only during the first days of ICU stay,
thus making it difficult to study the association between
MOD and IAH throughout the entire ICU stay.
Characteristics of IAH
WSACS gives special attention to the IAH classification;
this correlates with the patient’s profile, namely, whether
the patient is medical or surgical [17-21,32-34]. Classifi-
cation of IAH as acute and with high IAP grades (III-
IV) is typical for surgical patients, whereas classification
of IAH as subacute and with low-moderate IAP grades
(I-II) is characteristic for medical patients [17-21,35].
Our results in medical patients are consistent with this
observation. The IAH classification varies depending on
the study; however, no studies include all the classifica-
tion types currently recommended by WSACS. In sum-
mary, a complete classification is important for planning
future studies and comparing results, and the differen-
tiation between medical or surgical patients is, in our
opinion, necessary for a correct analysis based on the
differences with regard to the causes and evolution of
IAH in those two types of patient’s profile.
Fourteen patients reached grade III of IAH, and five
grade IV, but none of them developed ACS because a
sustained elevation of IAP > 20 mmHg associated with
organ deterioration was not detected. In concordance
with this, no patient required surgical abdominal
decompression.
Prognostic implications of IAH
Development of IAH has been described as an indepen-
dent predictor of mortality in mixed populations [20]. In
our study IAH was a non-independent predictor of mor-
tality, and this supports the fact that IAH was a marker
of mortality in association with other clinical factors. In
accordance with this, patients with IAH had higher
severity scores and number of CRF for IAH that can
independently increase mortality risk. In fact, the num-
ber of CRF during ICU stay was an independent predic-
tor of mortality in the group with IAH.
Table 10 Logistic regression model for predictors of mortality in the high risk group
Coefficients Odds ratio 95% Confidence interval p value
Age ≥65 yrs 2.057 3.82 2.08-29.28 .002
APACHE II score ≥20 1.614 5.02 1.11-22.70 .03
SOFA score maximum during ICU stay 0.224 1.25 1.03-1.51 .01
Positive cumulative fluid balance during ICU stay 1.730 5.64 1.50-21.14 .06
No. of categorized risk factors for IAH during ICU stay 1.200 3.32 0.94-11.72 .34
Increased abdominal content during ICU stay 1.007 2.73 0.34-21.78 .08
IAH 1.409 4.09 0.83-20.12
Constant -9.908
Predictors of mortality in the group with ≥2 categorized risk factors for IAH (87 patients). APACHE II, Acute Physiology and Chronic Health Evaluation; CI,
confidence interval; IAH, intra-abdominal hypertension; ICU, intensive care unit; SOFA, Sequential Organ Failure Assessment. Area under receiver operating
characteristic curve = 0.78; Hosmer-Lemeshow goodness-of-fit (x2 = 3.78; p = 0.870).
Table 11 Logistic regression model for predictors of mortality in the IAH group
Coefficients Odds ratio 95% confidence interval p value
Age ≥65 yrs 2.811 16.63 2.46-112.30 .004
SOFA score maximum during ICU stay 0.196 1.22 0.97-1.53 .09
No. of categorized risk factors for IAH during ICU stay 2.297 9.94 1.59-62.00 .01
Increased abdominal content during ICU stay 1.847 6.34 0.43-93.31 .17
Non-resolution of IAH 2.577 13.15 22.13-81.92 .006
Constant -13.953
Predictors of mortality in the patients with IAH (59 patients). CI, confidence interval; IAH, intra-abdominal hypertension; ICU, intensive care unit; SOFA, Sequential
Organ Failure Assessment. Area under receiver operating characteristic curve = 0.80
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medical patients, but non-resolution was an independent
predictor of mortality, resulting in a considerably high
OR (non-resolution meant that death was 13 times
more likely). Treatment of IAH was nonsurgical in all
cases and none developed ACS, although no conclusions
can be drawn in the absence of clinical intervention
data. Management guidelines for IAH have been pro-
posed by the WSACS [24] although they are based on
studies that analyze therapeutic strategies in isolation
and in different patient profiles [36-40].
Limitations of the study
IAP was not measured in all cases (only in those with
≥2 CRF), and patients with < 2 CRF and no IAP
recorded might have developed IAH during their ICU
stay (e.g., patients with mechanical ventilation and
therefore, diminished abdominal wall compliance but
with no RF in other categories and no IAP measured).
Therefore, the study followed the WSACS screening
recommendations but was not designed to validate them
in order to identify a subgroup of high risk patients for
IAH development, as compared with a low risk sub-
group. The study was underpowered to analyze each RF
of the four categories as predictors of IAH (small sam-
ple size) or the IAP level as a predictor of mortality (the
IAPmean in the patients with IAH were relatively low to
perform comparisons in the outcome). Not all patients
who had their IAP measured were sedated, which could
have caused a falsely elevated IAP. Although resolution
o fI A Hw a sap r o g n o s t i cf a c t o r ,o u rs t u d yw a sn o t
designed to focus on therapeutic management of IAH,
and no conclusions can be drawn or ascertainments can
be made about the strategies that were effective.
Conclusions
Critically ill medical patients admitted to the ICU with
high risk of IAH development (≥2C R F )h a v eh i g hm o r -
bidity, mortality, and incidence of IAH, so IAP should
be measured as recommended by the WSACS. In this
subgroup of patients, the presence of IAH is associated
with mortality as a non-independent risk factor, and
non-resolution of this process is an independent predic-
tor of mortality. Our study supports the implementation
of protocols based on WSACS guidelines for IAH
screening and assessment to allow an early approach to
this syndrome. Large, multicenter randomized con-
trolled clinical trials are needed to confirm our results
and to further promote the WSACS recommendations
regarding IAH screening and management.
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